IL-37 has been shown to be protective during the development of a number of cancers, including hepatocellular carcinoma (42, 43), colorectal cancer (44), non-small cell lung cancer (45), renal cell carcinoma and oral and cervical squamous cell carcinoma (46). Here, IL37 is linked to cancer.